Taking a cutting-edge weight-loss drug could help extremely obese patients drop enough pounds to be eligible for bariatric surgery, a new study shows.
-- a BMI of 70 or more -- are at higher risk of complications from surgery compared to people who weigh less.prior to surgery can lower that risk, but up to now nothing's been able to help patients lose enough weight to make a difference, researchers say.
However, new GLP-1 agonist medications like Ozempic, Wegovy and Zepbound have been shown to help people quickly shed pounds.The findings were presented Thursday at the American Society for Metabolic and Bariatric Surgery's annual meeting in San Diego.than other methods for those with extreme obesity,” said researcher Dr. Phil Schauer, director of the Metamor Metabolic Institute at Pennington Biomedical in Baton Rouge, La.
“Obesity must be viewed like other chronic diseases, where sometimes more than one therapy is necessary over time and for different reasons,” added Kurian, who was not involved in the study. Because this research was presented at a medical meeting, it should be considered preliminary until published in a peer-reviewed journal.SOURCE: American Society for Metabolic and Bariatric Surgery, news release, June 13, 2024There are many reasons for sudden weight gain when there are no changes in diet or exercise. Learn to identify the cause of your sudden weight gain.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
It's Safe to Take GLP-1 Weight Loss Meds Before Surgery: StudyDespite recent concerns that taking Ozempic, Wegovy or other GLP-1 medications might be unsafe before a surgery, a new review has uncovered no such danger.
Read more »
Use of GLP-1 Meds Have Risen 7-Fold Among Young AmericansThe number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds.
Read more »
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortagesThe tracker could be a valuable tool for Americans scrambling to find GLP-1s, such as Novo Nordisk’s weight loss injection Wegovy and diabetes drug…
Read more »
Deep discounts may benefit shoppers but may not help the economy, financial expert saysA Jacksonville financial expert said corporations slashing prices for inflation may help shoppers, but it isn’t guaranteed to be good for the economy.
Read more »
Survey Suggests One in Eight US Adults May Have Used a GLP-1 DrugA KFF poll also suggests half of the respondents who had tried these weight loss meds no longer took them, with many reporting difficulties paying for these drugs.
Read more »
CDC warns access to ADHD meds may be disrupted after arrests of health-care startup executivesThe arrests mark the DOJ's 1st criminal drug distribution prosecutions related to prescribing via telemedicine, the agency said.
Read more »